Integer Holdings Creates New Chief Operating Officer Role

Some changes are in store next year for Integer Holdings Corporation’s executive management team.

Payman Khales is set to assume the newly created role of chief operating officer (COO) during Q1 2025. Andrew Senn will take over as president of Cardio & Vascular.

Khales joined Integer Holdings in early 2018 as the president of Cardio & Vascular. Under his leadership, the business accelerated its sales and market penetration and achieved above-market growth.

As Integer’s COO, Khales will oversee both of Integer’s product categories (Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation) along with global operations and manufacturing strategy. “The role of COO will be focused on sharing best practices between the product categories and enhancing the execution and speed of Integer’s global operational excellence initiatives,” Integer Holdings President/CEO Joe Dziedzic said.

Before joining Integer, Khales was president of the Environmental Technologies business segment for CECO Environmental Corp., a diversified global provider of engineered technologies to the environmental, energy, and fluid handling and filtration industrial segments. Prior to that, he held several progressive executive leadership roles at Ingersoll Rand Company.

Khales earned an executive MBA from Indiana University’s Kelley School of Business, and a bachelor of science degree in mechanical engineering from École Polytechnique de Montréal.

“I am honored to become Integer’s chief operating officer and look forward to working closely with Jim Stephens (president CRM&N), John Harris (EVP, Global Operations and Manufacturing Strategy) and Andrew in his new role,” Khales stated. “Together we will continue to serve our customers through development of high-quality complex products and processes, achieving above-market growth over the long term.”

Senn has been with Integer for 18 years, including 15 years in the Cardio & Vascular division; his most recent role there has been senior vice president, Strategy, Business Development, and Investor Relations. Senn will apply his deep technical knowledge and extensive leadership experience gained through program management, R&D, marketing, and sales roles at Integer and St. Jude Medical Inc., to further guide the Cardio & Vascular product category along its growth journey.

Senn was director of Program Management responsible for electrophysiology systems at St. Jude Medical before joining Integer.

Senn earned an MBA with concentrations in finance, marketing, and medical industry leadership from the Carlson School of Management at the University of Minnesota and a master of science degree in technology management. He also earned a bachelor of science degree in mechanical engineering and a bachelor of arts degree in business administration from the University of St. Thomas.

“During his time with Integer, Payman has done an exceptional job leading the global Cardio & Vascular product category by establishing a successful market/customer-based strategy that has driven above market growth and improved profitability. With his proven expertise in commercial business leadership and his deep understanding of Integer’s product development and manufacturing operations, he is uniquely positioned to take on a greater responsibility within the company,” Dziedzic stated. “Andrew has served successfully in many roles at Integer, from research and development to sales to the head of corporate strategy. He has a deep knowledge of the industry and a strong customer focus and is ideally suited to continue the growth of our Cardio & Vascular business.”

Integer Holdings Corporation reportedly is one of the world’s largest medical device contract development and manufacturing organizations, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner to medical device companies and OEMs, Integer provides innovative products and solutions. The company’s brands include Greatbatch Medical and Lake Region Medical.